ePharma Insights and Prescriptions Podcast Series

ePharma Insights and Perscriptions Mark Senak – author of the leading blog "EyeOnFDA,"

Part 1: Senak provides an introduction to the regulatory landscape and tackles the dilemmic question:
Part 1: pdf | mp3

Part 2: In Part Two of a four-part interview for IIR’s new podcast series – “ePharma Insights & Prescriptions” – Senak suggests that when it comes to social media for pharma marketers the choice is obvious: Move! The key, however, is to proceed with caution. Accordingly, we’ll discuss some common ePharma marketing mistakes. We’ll also weigh ROI considerations versus the opportunity cost of not having a robust social media presence and we’ll speculate on where the FDA may be headed in the near term.
Part 2: pdf | mp3

Part 3: Twitter is to modern pharma marketing what plumbing is to a house: you can’t do without. Unfortunately, the FDA isn’t much of a plumber and it appears we have a clog. In Part Three of “ePharma Insights & Prescriptions’” interview with healthcare public affairs pro Mark Senak, we’ll explore the increasing digital divide between social media technology and regulatory policy, starting with some Twitter talk. We’ll also explore the rise of the “semantic” Web and its potential for enabling an unprecedented level of de-risked relationships between pharma and patients.
Part 3: pdf | mp3

ePharma Insights and Perscriptions Jennifer Shine Dyer, MD, MPH, Nationwide Children's Hospital on mHealth
pdf | mp3